0001181431-13-055216.txt : 20131025 0001181431-13-055216.hdr.sgml : 20131025 20131025204201 ACCESSION NUMBER: 0001181431-13-055216 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130924 FILED AS OF DATE: 20131025 DATE AS OF CHANGE: 20131025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 CITY: SAN DIEGO STATE: CA ZIP: 92122 BUSINESS PHONE: 858-207-4264 MAIL ADDRESS: STREET 1: 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 CITY: SAN DIEGO STATE: CA ZIP: 92122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TIDMARSH GEORGE F CENTRAL INDEX KEY: 0001287235 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-24274 FILM NUMBER: 131171863 4/A 1 rrd393532.xml FORM 4/A X0306 4/A 2013-09-24 2013-10-11 0 0000920465 LA JOLLA PHARMACEUTICAL CO LJPC 0001287235 TIDMARSH GEORGE F 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122 1 1 0 0 President, CEO and Sec'y Common Stock 2013-09-24 4 A 0 1071429 0.07 A 69404300 D This amendment is being filed solely to correct the number of securities acquired and beneficially owned following the reported transactions, which were reported incorrectly in the original Form 4 due to an administrative error. The securities were acquired by the Reporting Person pursuant to a Securities Purchase Agreement made and entered into on September 24, 2013 by and among the Issuer, the Reporting Person and other purchasers. By: /s/ George F. Tidmarsh 2013-10-25